Microbot Medical MBOT Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $3.66M-6.5% | $3.91M-42.1% | $6.76M+63.4% | $4.14M+28.5% | $3.22M+3.3% | ||
| $68.84M-7.8% | $74.68M+1.7% | $73.45M+157% | $28.59M+5.2% | $27.17M+1,053% | ||
| —— | —— | —— | —— | —— | ||
| $3.13M+207% | $1.02M— | —— | —— | —— | ||
| $76.53M-4.1% | $79.82M-1.2% | $80.79M+146% | $32.89M+7.3% | $30.66M+427% | ||
| $188K+102% | $93K+19.2% | $78K+4.0% | $75K-3.8% | $78K-2.5% | ||
| $78.07M-4.3% | $81.54M-0.3% | $81.76M+147% | $33.13M+7.2% | $30.89M+412% | ||
| $1.09M+112% | $511K+0.4% | $509K+1.2% | $503K+170% | $186K+12.7% | ||
| $3.39M-1.0% | $3.42M+16.6% | $2.93M+7.6% | $2.73M+44.1% | $1.89M-23.0% | ||
| $3.96M-0.7% | $3.99M+12.8% | $3.54M+27.5% | $2.77M+42.9% | $1.94M-22.4% | ||
| 120M0.0% | 120M0.0% | 120M0.0% | 120M+100% | 60M0.0% | ||
| -$107.76M-3.5% | -$104.09M-3.4% | -$100.62M-3.7% | -$97.05M-3.7% | -$93.55M-2.9% | ||
| $74.11M-4.4% | $77.55M-0.9% | $78.22M+158% | $30.36M+4.9% | $28.95M+720% | ||
| $78.07M-4.3% | $81.54M-0.3% | $81.76M+147% | $33.13M+7.2% | $30.89M+412% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Microbot Medical's total assets?
- Microbot Medical (MBOT) holds $78.1M in total assets, up 152.7% year over year.
- How much debt does Microbot Medical have?
- Microbot Medical carries $898.0K in total debt against $74.1M of shareholders' equity, a debt-to-equity ratio of 0.01.
- How much cash does Microbot Medical have?
- Microbot Medical holds $3.7M in cash and equivalents.
- Can Microbot Medical cover its short-term obligations?
- Its current ratio is 22.59 — current assets exceed current liabilities.
- Where does Microbot Medical's balance sheet data come from?
- Every line is extracted from Microbot Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
